Table 1.
Preprocedural Demographics and Comorbidities for Patients with Symptomatic PAD Undergoing Intervention (n = 257 Patients)
| Variable | Depressed | Nondepressed | p value |
|---|---|---|---|
| Age (y) | 64.3 | 69.3 | .0002 |
| Race White (%) | 91.1 | 85.0 | .27 |
| Race African-American (%) | 8.9 | 13.2 | |
| Race Hispanic (%) | 0 | 1.8 | |
| Diabetes (%) | 44.4 | 49.7 | .42 |
| Hypertension (%) | 82.2 | 90.4 | .06 |
| Dyslipidemia (%) | 63.3 | 67.7 | .42 |
| Statin use (%) | 44.4 | 41.9 | .70 |
| Tobacco use (ever) (%) | 94.4 | 88.0 | .10 |
| Tobacco use (within 1 year) (%) | 72.2 | 50.1 | .001 |
| Coronary artery disease (%) | 64.4 | 66.5 | .74 |
| Renal disease (%) | 20.0 | 31.7 | .04 |
| Pulmonary disease (%) | 25.6 | 50.9 | <.0001 |
| Previous coronary revascularization (%) | 17.8 | 25.7 | .15 |
| Cerebrovascular disease (%) | 30.0 | 38.9 | .15 |
| Previous carotid endarterectomy (%) | 7.8 | 10.8 | .44 |
| Previous PAD revascularization (%) | 18.9 | 21.0 | .69 |
| Previous contralateral amputation (%) | 4.4 | 4.2 | .92 |
PAD: peripheral arterial disease